Heptares Therapeutics
Jordan Ashton is a Senior Scientist at CHARM Therapeutics since June 2024, previously serving as a Research Scientist and Scientist at Nxera Pharma from September 2019 to May 2024. Jordan Ashton completed a degree at the University of York from 2016 to 2020, bringing a solid educational foundation to a career in scientific research.
Heptares Therapeutics
Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, StabilisedReceptors), overcoming a major limiting factor to the development of new drugs targeting this group.